SearcharxivSearch

arXiv subjects

Samuel J. Landry

Publications and source records attributed to Samuel J. Landry.

5 recordsLinked to original sources

Structure-Regularized Interpretable TCR-Epitope Prediction

T cell receptor (TCR)-epitope binding prediction is essential for understanding adaptive immunity and developing immunotherapies. Existing sequence- and structure-based models often generalize poorly to unseen epitopes and provide limited interpretability. Furthermore, the impact of generated structures on model learning remains unclear. We present TCR-SRIM, a structure-regularized interpretable-by-design model that combines protein language model embeddings with interpretable contact prototypes to capture residue-level TCR-epitope interactions. TCR-SRIM achieves state-of-the-art predictive performance and improved interpretation quality on the TCR-XAI benchmark. Using its inherent interpretability, we further evaluate the effect of generated structures on model learning. While structures predicted by AlphaFold3, TCRModel2, and tFold-TCR yield competitive performance, they lead to less accurate interaction patterns and reduced binding-site diversity than experimentally-resolved structures. Our results highlight limitations of current structure prediction models for TCR-epitope learning and demonstrate the value of interpretable-by-design models for studying generated biological structures.

q-bio.BM

APLSuite: An Integrated Suite for CD4+ T Cell Epitope Prediction via Antigen Processing Likelihood

Computational epitope prediction is a critical tool for exploring and understanding CD4+ T cell-mediated immune responses, a key aspect of adaptive immunity. While existing computational methods primarily focus on supervised learning approaches, they often overlook the essential role of antigen processing in determining binding specificity. To address this limitation, our group developed Antigen Processing Likelihood (APL), an algorithm that integrates crystallographic B-factor, solvent accessible surface area (SASA), hydrogen exchange protection factors (COREX), and sequence entropy. In this paper we introduce APLSuite, a comprehensive and lightweight software suite designed to streamline APL-based epitope prediction. APLSuite integrates distributed RESTful API services, a Python client for data aggregation and processing, a data science tool for efficient epitope computation, and a user-friendly graphical user interface for non-coding users. It provides a seamless and efficient pipeline for APL calculation and epitope prediction that can be finished in minutes with GPU-acceleration, which has not been implemented by existed tools. This flexible and extensible software suite is deployable on desktop and cloud environments, offering both guided and customizable workflows to meet diverse research needs in immunology research and immunotherapy development. (The project page for this work is available at: https://tulane-mettu-landry-lab.github.io/blogs/APLSuite/)

q-bio.BM

Quantifying Cross-Attention Interaction in Transformers for Interpreting TCR-pMHC Binding

CD8+ "killer" T cells and CD4+ "helper" T cells play a central role in the adaptive immune system by recognizing antigens presented by Major Histocompatibility Complex (pMHC) molecules via T Cell Receptors (TCRs). Modeling binding between T cells and the pMHC complex is fundamental to understanding basic mechanisms of human immune response as well as in developing therapies. While transformer-based models such as TULIP have achieved impressive performance in this domain, their black-box nature precludes interpretability and thus limits a deeper mechanistic understanding of T cell response. Most existing post-hoc explainable AI (XAI) methods are confined to encoder-only, co-attention, or model-specific architectures and cannot handle encoder-decoder transformers used in TCR-pMHC modeling. To address this gap, we propose Quantifying Cross-Attention Interaction (QCAI), a new post-hoc method designed to interpret the cross-attention mechanisms in transformer decoders. Quantitative evaluation is a challenge for XAI methods; we have compiled TCR-XAI, a benchmark consisting of 274 experimentally determined TCR-pMHC structures to serve as ground truth for binding. Using these structures we compute physical distances between relevant amino acid residues in the TCR-pMHC interaction region and evaluate how well our method and others estimate the importance of residues in this region across the dataset. We show that QCAI achieves state-of-the-art performance on both interpretability and prediction accuracy under the TCR-XAI benchmark.

cs.CE

TCR-EML: Explainable Model Layers for TCR-pMHC Prediction

T cell receptor (TCR) recognition of peptide-MHC (pMHC) complexes is a central component of adaptive immunity, with implications for vaccine design, cancer immunotherapy, and autoimmune disease. While recent advances in machine learning have improved prediction of TCR-pMHC binding, the most effective approaches are black-box transformer models that cannot provide a rationale for predictions. Post-hoc explanation methods can provide insight with respect to the input but do not explicitly model biochemical mechanisms (e.g. known binding regions), as in TCR-pMHC binding. ``Explain-by-design'' models (i.e., with architectural components that can be examined directly after training) have been explored in other domains, but have not been used for TCR-pMHC binding. We propose explainable model layers (TCR-EML) that can be incorporated into protein-language model backbones for TCR-pMHC modeling. Our approach uses prototype layers for amino acid residue contacts drawn from known TCR-pMHC binding mechanisms, enabling high-quality explanations for predicted TCR-pMHC binding. Experiments of our proposed method on large-scale datasets demonstrate competitive predictive accuracy and generalization, and evaluation on the TCR-XAI benchmark demonstrates improved explainability compared with existing approaches.

q-bio.QM

Rational Multi-Modal Transformers for TCR-pMHC Prediction

T cell receptor (TCR) recognition of peptide-MHC (pMHC) complexes is fundamental to adaptive immunity and central to the development of T cell-based immunotherapies. While transformer-based models have shown promise in predicting TCR-pMHC interactions, most lack a systematic and explainable approach to architecture design. We present an approach that uses a new post-hoc explainability method to inform the construction of a novel encoder-decoder transformer model. By identifying the most informative combinations of TCR and epitope sequence inputs, we optimize cross-attention strategies, incorporate auxiliary training objectives, and introduce a novel early-stopping criterion based on explanation quality. Our framework achieves state-of-the-art predictive performance while simultaneously improving explainability, robustness, and generalization. This work establishes a principled, explanation-driven strategy for modeling TCR-pMHC binding and offers mechanistic insights into sequence-level binding behavior through the lens of deep learning.

cs.CE